TRIM26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.828640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.561990E-01
Normal-vs-Stage2
2.001200E-01
Normal-vs-Stage3
1.149800E-01
Normal-vs-Stage4
7.134000E-01
Stage1-vs-Stage2
6.425000E-01
Stage1-vs-Stage3
4.227800E-01
Stage1-vs-Stage4
2.118400E-01
Stage2-vs-Stage3
1.989630E-01
Stage2-vs-Stage4
3.321800E-01
Stage3-vs-Stage4
1.137180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.901410E-01
Normal-vs-AfricanAmerican
2.760000E-01
Normal-vs-Asian
2.469000E-01
Caucasian-vs-AfricanAmerican
9.114000E-01
Caucasian-vs-Asian
9.686000E-01
AfricanAmerican-vs-Asian
9.032600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.157600E-01
Normal-vs-Female
1.548620E-01
Male-vs-Female
9.695600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.156800E-01
Normal-vs-Age(41-60Yrs)
1.363240E-01
Normal-vs-Age(61-80Yrs)
2.111200E-01
Normal-vs-Age(81-100Yrs)
3.317800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.027200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.129600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.045800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.814200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.630800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.782400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.126400E-01
Normal-vs-Daily Drinker
5.979000E-03
Normal-vs-Weekly Drinker
3.339200E-01
Normal-vs-Occasional Drinker
2.240400E-01
Normal-vs-Social Drinker
1.834430E-01
Non Drinker-vs-Daily Drinker
4.774200E-02
Non Drinker-vs-Weekly Drinker
5.896000E-01
Non Drinker-vs-Occasional Drinker
1.895450E-01
Non Drinker-vs-Social Drinker
7.306400E-01
Daily Drinker-vs-Weekly Drinker
1.622200E-02
Daily Drinker-vs-Occasional Drinker
1.983670E-04
Daily Drinker-vs-Social Drinker
1.359910E-02
Weekly Drinker-vs-Occasional Drinker
6.561000E-01
Weekly Drinker-vs-Social Drinker
8.191600E-01
Occasional Drinker-vs-Social Drinker
3.786800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.167220E-01
Normal-vs-Grade 2
1.957960E-02
Normal-vs-Grade 3
2.997700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.328050E-02
Grade 1-vs-Grade 3
8.268500E-02
Grade 1-vs-Grade 4
1.167220E-01
Grade 2-vs-Grade 3
4.858800E-01
Grade 2-vs-Grade 4
1.957960E-02
Grade 3-vs-Grade 4
2.997700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.699600E-01
Normal-vs-NonDiabetic
1.309770E-01
Diabetic-vs-NonDiabetic
9.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.387210E-01
Normal-vs-NoPancreatitis
1.723620E-01
Pancreatitis-vs-NoPancreatitis
9.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.990160E-01
Normal-vs-N1
2.001800E-01
N0-vs-N1
9.001200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.597600E-01
Normal-vs-TP53-NonMutant
5.196200E-01
TP53-Mutant-vs-TP53-NonMutant
8.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
